Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast® - Related Studies

Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®

This study is not yet open for participant recruitment.

Study NCT00668200. Last updated on April 25, 2008. Information provided by Novartis

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Paget's Disease of the Bone
		Hypocalcemia

2	Additional conditions recognized in this trial
		Bone Diseases
		Osteitis Deformans

3	More general conditions related to this trial
		Calcium Metabolism Disorders
		Metabolic Diseases
		Musculoskeletal Diseases
		Water-Electrolyte Imbalance

4	Interventions listed in this trial
		Reclast®

5	Additional drug interventions recognized in this trial
		Zoledronic acid

6	More general drug interventions related to this trial
		Bone Density Conservation Agents
		Pharmacologic Actions
		Physiological Effects of Drugs

7	Sponsors listed in this trial
		Novartis